
Abstract Computed tomography (CT) is the primary imaging modality for the rapid assessment of trauma patients, where timely and accurate diagnosis is essential for guiding management and improving outcomes. Photon-counting detector CT (PCD-CT) represents the most significant technological advance in CT in recent decades, overcoming key limitations of conventional energy-integrating detector systems through direct photon conversion and spectral discrimination. This narrative review critically synthesizes the current evidence on PCD-CT in trauma imaging, highlighting its technical principles, clinical applications, limitations, and future perspectives. Available data demonstrate that PCD-CT provides ultra-high spatial resolution, comprehensive spectral imaging, reduced beam-hardening and metal artifacts, and improved radiation- and contrast-dose efficiency compared with conventional CT. These advantages facilitate more accurate assessment of osseous injuries, vascular trauma, active hemorrhage, pulmonary and bowel injuries, occult fractures, and periprosthetic complications, while enabling advanced tissue characterization through material decomposition techniques. However, much of the available evidence is derived from small clinical cohorts, non-trauma populations, or studies extrapolated from dual-energy CT. Moreover, PCD-CT does not replace magnetic resonance imaging for soft-tissue or bone marrow evaluation, and its broader implementation remains constrained by cost, limited scanner availability, and workflow considerations. Large prospective multicenter trauma studies are needed to determine whether the technical advantages of PCD-CT translate into improved diagnostic accuracy, clinical decision-making, workflow efficiency, and ultimately patient outcomes.
Abstract Early disease detection, precise prognosis, and effective treatment planning heavily depend on medical image diagnosis. Because manual image analysis requires substantial clinical expertise, computer-aided systems have become essential. This study examines various Convolutional Neural Network (CNN) algorithms for anomaly detection and classification in medical scans. Following a systematic search across the IEEE Xplore, Web of Science, and Google Scholar databases, 91 publications were included in our synthesis. We provide a structured comparative analysis of prominent networks, including U-Net, ResNet, GoogLeNet, and customized models, evaluating their applications, developments, and implementation challenges. The findings of this review demonstrate that fine-tuning key architectural parameters can significantly improve core diagnostic metrics, specifically accuracy, sensitivity, F1 score, precision, Dice Score Coefficient, and AUC . Ultimately, this work maps the current state of deep learning in healthcare and outlines critical areas for future inquiry.
Molecular imaging (MI) is an unavoidable technology in precision medicine, enabling the picturing of biological activities at cellular and cellular levels. Positron emission tomography (PET), magnetic resonance imaging (MRI), and single-photon emission computed tomography (SPECT), offer harmonizing viewpoints on physiology, metabolism, as well as anatomy. Integration of these methods through hybrid platforms provides a strong, multidimensional approach for timely disease diagnosis, tailored diagnosis, and medication monitoring. This review studies the fashionable background and clinical importance of PET, MRI, and SPECT in accurate screening, emphasizing their roles in oncology, neurology, cardiology, and so on. We examine new progresses in radiotracer formation, quantifiable imaging biomarkers, and AI-aided image analyzing, which are enhancing sensitivity, precision, and prognosis precision. The review moreover studies imminent progresses comprising dynamic multimodal imaging, radiogenomics, immune-targeted imaging, and modified theranostics. Nevertheless such progresses, like infrastructural limitations, radiotracer shortage, data amalgamation particulars, and ethical dilemmas. These problems must be overwhelmed to attain reasonable and scalable application of MI methods across many sustainable healthcare systems. MI is established to progress from an additional diagnostic technique to a proactive, adaptive instrument significant to tailored healthcare. Through the combination of biological awareness and technology progress, PET, MRI, and SPECT will continue in their progression as vital elements of the precision drug framework altering our approaches of disease detection, understanding, and medication.